Latest Breaking News On - Clarkson disease - Page 1 : comparemela.com

/PRNewswire/ PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics,.

South koreaTaejon gwangyoksiKirk drueyJin san yooPharmabcine incIr pr teamBusiness development teamIdiopathic systemic capillary leak syndromeClarkson diseaseScience advancesVascular inflammation sectionOrphan drug designationSystemic capillary leakAge related macular degenerationTumor microenvironment